|
1
|
Kang YS, Ko GJ, Lee MH, Song HK, Han SY,
Han KH, Kim HK, Han JY and Cha DR: Effect of eplerenone, enalapril
and their combination treatment on diabetic nephropathy in type II
diabetic rats. Nephrol Dial Transplant. 24:73–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miana M, de Las Heras N, Rodriguez C,
Sanz-Rosa D, Martin-Fernandez B, Mezzano S, Lahera V,
Martinez-Gonzalez J and Cachofeiro V: Effect of eplerenone on
hypertension-associated renal damage in rats: Potential role of
peroxisome proliferator activated receptor gamma (PPAR-γ). J
Physiol Pharmacol. 62:87–94. 2011.PubMed/NCBI
|
|
3
|
Li Y, Wang X, Zhang L, Yuan X, Hao J, Ni J
and Hao L: Upregulation of allograft inflammatory factor-1
expression and secretion by macrophages stimulated with aldosterone
promotes renal fibroblasts to a profibrotic phenotype. Int J Mol
Med. 42:861–872. 2018.PubMed/NCBI
|
|
4
|
Deininger MH, Meyermann R and Schluesener
HJ: The allograft inflammatory factor-1 family of proteins. FEBS
Lett. 514:115–121. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu G, Ma H, Jiang L and Zhao Y: Allograft
inflammatory factor-1 and its immune regulation. Autoimmunity.
40:95–102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Kelemen SE and Autieri MV: AIF-1
expression modulates proliferation of human vascular smooth muscle
cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc
Biol. 24:1217–1222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watano K, Iwabuchi K, Fujii S, Ishimori N,
Mitsuhashi S, Ato M, Kitabatake A and Onoé K: Allograft
inflammatory factor-1 augments production of interleukin-6, −10 and
−12 by a mouse macrophage line. Immunology. 104:307–316. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Del Galdo F, Artlett CM and Jimenez SA:
The role of allograft inflammatory factor 1 in systemic sclerosis.
Curr Opin Rheumatol. 18:588–593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Mei C, Du R and Shen L: Protective
effect of allograft inflammatory factor-1 on the apoptosis of
fibroblast-like synoviocytes in patients with rheumatic arthritis
induced by nitro oxide donor sodium nitroprusside. Scand J
Rheumatol. 42:349–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tian Y, Kelemen SE and Autieri MV:
Inhibition of AIF-1 expression by constitutive siRNA expression
reduces macrophage migration, proliferation, and signal
transduction initiated by atherogenic stimuli. Am J Physiol Cell
Physiol. 290:C1083–C1091. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lloberas N, Cruzado JM, Franquesa M,
Herrero-Fresneda I, Torras J, Alperovich G, Rama I, Vidal A and
Grinyó JM: Mammalian target of rapamycin pathway blockade slows
progression of diabetic kidney disease in rats. J Am Soc Nephrol.
17:1395–1404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen G, Dong Z, Liu H, Liu Y, Duan S, Liu
Y, Liu F and Chen H: mTOR signaling regulates protective activity
of transferred CD4+Foxp3+ T cells in repair of acute kidney injury.
J Immunol. 197:3917–3926. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma SK, Joo SY, Kim CS, Choi JS, Bae EH,
Lee J and Kim SW: Increased phosphorylation of PI3K/Akt/mTOR in the
obstructed kidney of rats with unilateral ureteral obstruction.
Chonnam Med J. 49:108–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang LL, Nikolic-Paterson DJ, Ma FY and
Tesch GH: Aldosterone induces kidney fibroblast proliferation via
activation of growth factor receptors and PI3K/MAPK signaling.
Nephron, Exp Nephrol. 120:E115–E122. 2012. View Article : Google Scholar
|
|
15
|
Toba H, Mitani T, Takahashi T, Imai N,
Serizawa R, Wang J, Kobara M and Nakata T: Inhibition of the renal
renin-angiotensin system and renoprotection by pitavastatin in type
1 diabetes. Clin Exp Pharmacol Physiol. 37:1064–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shan Q, Zhuang J, Zheng G, Zhang Z, Zhang
Y, Lu J and Zheng Y: Troxerutin reduces kidney damage against
BDE-47-induced apoptosis via inhibiting NOX2 activity and
increasing Nrf2 activity. Oxid Med Cell Longev. 2017:60346922017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karim AS, Reese SR, Wilson NA, Jacobson
LM, Zhong W and Djamali A: Nox2 is a mediator of ischemia
reperfusion injury. Am J Transplant. 15:2888–2899. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fukuda M, Nakamura T, Kataoka K, Nako H,
Tokutomi Y, Dong YF, Ogawa H and Kim-Mitsuyama S: Potentiation by
candesartan of protective effects of pioglitazone against type 2
diabetic cardiovascular and renal complications in obese mice. J
Hypertens. 28:340–352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aminzadeh MA, Nicholas SB, Norris KC and
Vaziri ND: Role of impaired Nrf2 activation in the pathogenesis of
oxidative stress and inflammation in chronic tubulo-interstitial
nephropathy. Nephrol Dial Transplant. 28:2038–2045. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang SY, Lo CS, Zhao XP, Liao MC, Chenier
I, Bouley R, Ingelfinger JR, Chan JS and Zhang SL: Overexpression
of angiotensinogen downregulates aquaporin 1 expression via
modulation of Nrf2-HO-1 pathway in renal proximal tubular cells of
transgenic mice. J Renin Angiotensin Aldosterone Syst.
17:14703203166687372016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak K and Schmittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brown NJ: Contribution of aldosterone to
cardiovascular and renal inflammation and fibrosis. Nat Rev
Nephrol. 9:459–469. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Autieri MV and Carbone CM: Overexpression
of allograft inflammatory factor-1 promotes proliferation of
vascular smooth muscle cells by cell cycle deregulation.
Arterioscler Thromb Vasc Biol. 21:1421–1426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schluesener HJ, Seid K, Kretzschmar J and
Meyermann R: Allograft-inflammatory factor-1 in rat experimental
autoimmune encephalomyelitis, neuritis, and uveitis: Expression by
activated macrophages and microglial cells. Glia. 24:244–251. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian Y, Jain S, Kelemen SE and Autieri MV:
AIF-1 expression regulates endothelial cell activation, signal
transduction, and vasculogenesis. Am J Physiol Cell Physiol.
296:C256–C266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsubata Y, Sakatsume M, Ogawa A, Alchi B,
Kaneko Y, Kuroda T, Kawachi H, Narita I, Yamamoto T and Gejyo F:
Expression of allograft inflammatory factor-1 in kidneys: A novel
molecular component of podocyte. Kidney Int. 70:1948–1954. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fukui M, Tanaka M, Asano M, Yamazaki M,
Hasegawa G, Imai S, Fujinami A, Ohta M, Obayashi H and Nakamura N:
Serum allograft inflammatory factor-1 is a novel marker for
diabetic nephropathy. Diabetes Res Clin Pract. 97:146–150. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Y, Vassetzky Y and Dokudovskaya S:
mTORC1 pathway in DNA damage response. Biochim Biophys Acta Mol
Cell Res. 1865:1293–1311. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kattla JJ, Carew RM, Heljic M, Godson C
and Brazil DP: Protein kinase B/Akt activity is involved in renal
TGF-beta1-driven epithelial-mesenchymal transition in vitro and in
vivo. Am J Physiol Renal Physiol. 295:F215–F225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meadows KN, Iyer S, Stevens MV, Wang D,
Shechter S, Perruzzi C, Camenisch TD and Benjamin LE: Akt promotes
endocardial-mesenchyme transition. J Angiogenes Res. 1:22009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ghosh Choudhury G and Abboud HE: Tyrosine
phosphorylation-dependent PI 3 kinase/Akt signal transduction
regulates TGFbeta-induced fibronectin expression in mesangial
cells. Cell Signal. 16:31–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Runyan CE, Schnaper HW and Poncelet AC:
The phosphatidylinositol 3-kinase/Akt pathway enhances
Smad3-stimulated mesangial cell collagen I expression in response
to transforming growth factor-beta1. J Biol Chem. 279:2632–2639.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Asaba K, Tojo A, Onozato ML, Goto A, Quinn
MT, Fujita T and Wilcox CS: Effects of NADPH oxidase inhibitor in
diabetic nephropathy. Kidney Int. 67:1890–1898. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
You YH, Okada S, Ly S, Jandeleit-Dahm K,
Barit D, Namikoshi T and Sharma K: Role of Nox2 in diabetic kidney
disease. Am J Physiol Renal Physiol. 304:F840–F848. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Johar S, Cave AC, Narayanapanicker A,
Grieve DJ and Shah AM: Aldosterone mediates angiotensin II-induced
interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.
FASEB J. 20:1546–1548. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Numazawa S and Yoshida T: Nrf2-dependent
gene expressions: A molecular toxicological aspect. J Toxicol Sci.
29:81–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oh CJ, Kim JY, Choi YK, Kim HJ, Jeong JY,
Bae KH, Park KG and Lee IK: Dimethylfumarate attenuates renal
fibrosis via NF-E2-related factor 2-mediated inhibition of
transforming growth factor-β/Smad signaling. PLoS One.
7:e458702012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Queisser N, Oteiza PI, Link S, Hey V,
Stopper H and Schupp N: Aldosterone activates transcription factor
Nrf2 in kidney cells both in vitro and in vivo. Antioxid Redox
Signal. 21:2126–2142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Queisser N, Happ K, Link S, Jahn D, Zimnol
A, Geier A and Schupp N: Aldosterone induces fibrosis, oxidative
stress and DNA damage in livers of male rats independent of blood
pressure changes. Toxicol Appl Pharmacol. 280:399–407. 2014.
View Article : Google Scholar : PubMed/NCBI
|
